Adrenomedullin vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adrenomedullin (ADM) is a 52-amino acid vasoactive peptide first isolated from human pheochromocytoma tissue in 1993. It is now recognized as a pleiotropic hormone produced widely throughout the body, with highest expression in the adrenal medulla, heart, lung, kidney, and vascul...
Calculate Adrenomedullin dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Adrenomedullin | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Clinical |
| Half-Life | 22 min (plasma) | 10-15 min (plasma) |
| Typical Dose | 2-10 ng/kg/min (IV infusion) | 30-300 mcg/kg/day (IV) |
| Frequency | Acute infusion or short course | Continuous 48-hour infusion (trials) |
| Route | Intravenous, Subcutaneous | Intravenous (infusion) |
| FDA Status | Not approved | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.